Amplification of gene expression using both 5'- and 3'-untranslated regions of GLUT1 glucose transporter mRNA

Molecular Brain Research

Volumn 63, Issue 2, 1999, Pages 371-374

  Boado, Ruben J ^a   Pardridge, William M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Gene delivery; Gene therapy; Glucose transporter; Post transcription; Reporter gene

Indexed keywords

GLUCOSE TRANSPORTER; MESSENGER RNA;

ANIMAL CELL; ARTICLE; BRAIN; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REPORTER GENE;

3' UNTRANSLATED REGIONS; 5' UNTRANSLATED REGIONS; BRAIN; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; GENE AMPLIFICATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENES, REPORTER; GLUCOSE TRANSPORTER TYPE 1; HUMANS; LUCIFERASES; MONOSACCHARIDE TRANSPORT PROTEINS; NERVE TISSUE PROTEINS; RNA, MESSENGER;

ANIMALIA;

EID: 0033534409     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(98)00280-0     Document Type: Article

References (25)

1. Anderson W.F. Human gene therapy. Science. 256:1992;808-813.
2. Bauer T.R., Osborne W.R.A., Kwok W.W., Hickstein D.D. Expression from leukocyte integrin promoters in viral vectors. Hum. Gene Ther. 5:1994;709-716.
3. - SCID: initial trial results after 4 years. Science. 270:1995;475-480.
4. Boado R.J. Brain-derived peptides increase the expression of a blood-brain barrier GLUT1 glucose transporter reporter gene. Neurosci. Lett. 220:1996;53-56.
5. Boado R.J., Pardridge W.M. Glucose deprivation causes post-transcriptional enhancement of brain capillary endothelial glucose transporter gene expression via GLUT1 mRNA stabilization. J. Neurochem. 60:1993;2290-2296.
6. Boado R.J., Pardridge W.M. The 5′-untranslated region of GLUT1 glucose transporter mRNA causes differential regulation of translational rate in plant and animal systems. Comp. Biochem. Physiol. 118B:1997;309-312.
7. Boado R.J., Black K.L., Pardridge W.M. Gene expression of GLUT3 and GLUT1 glucose transporters in human brain tumors. Mol. Brain Res. 27:1994;51-57.
8. Boado R.J., Tsukamoto H., Pardridge W.M. Evidence for translational control elements within the 5′-untranslated region of GLUT1 glucose transporter mRNA. J. Neurochem. 67:1996;1335-1343.
9. - immunodeficient patients. Science. 270:1995;470-475.
10. Burd C.G., Dreyfuss G. Conserved structures and diversity of functions of RNA-binding proteins. Science. 265:1994;615-621.
11. Dillon N., Grosveld F. Transcriptional regulation of multigene loci. Trends Genet. 9:1993;134-137.
12. Duret L., Dorkeld F., Gautier C. Strong conservation of non-coding sequences during vertebrates evolution: potential involvement in post-transcriptional regulation of gene expression. Nucleic Acids Res. 21:1993;2315-2322.
13. Dwyer K.J., Boado R.J., Pardridge W.M. Cis-element/cytoplasmic protein interaction within the 3′-untranslated region of the GLUT1 glucose transporter mRNA. J. Neurochem. 66:1996;449-458.
14. Henics T., Sanfridson A., Hamilton B.J., Nagy E., Rigby W.F. Enhanced stability of interleukin-2 mRNA in MLA 144 cells. Possible role of cytoplasmic AU-rich sequence-binding proteins. J. Biol. Chem. 269:1994;5377-5383.
15. Hentze M.W. eIF4G: a multiple ribosome adapter? Science. 275:1997;500-501.
16. Kakinuma A., Chazenbalk G., Filetti S., Mclachlan S.M., Rapoport B. Both the 5′ and 3′ noncoding regions of the thyrotropin receptor messenger ribonucleic acid influence the level of receptor protein expression in transfected mammalian cells. Endocrinology. 137:1996;2664-2669.
17. Lorenzini E.C., Scheffler I.E. Co-operation of the 5′ and 3′ untranslated regions of ornithine decarboxylase mRNA and inhibitory role of its 3′ untranslated region in regulating the translation efficiency of hybrid RNA species via cellular factor. Biochem. J. 326:1997;361-367.
18. Marshall E. Less hype, more biology needed for gene therapy. Science. 270:1995;1751-1751.
19. Novak U., Harris E.A.S., Forrester W., Groudin M., Gelinas R. High-level β-globin expression after retroviral transfer of locus activation region-containing human β-globin gene derivatives into murine erythroleukemia cells. Proc. Natl. Acad. Sci. USA. 87:1990;3386-3390.
20. W.M. Pardridge, R.J. Boado, Molecular cloning and regulation of gene expression of blood-brain barrier glucose transporter, in: The Blood-Brain Barrier: Cellular and Molecular Biology, Raven Press, New York, 1993, pp. 395-440.
21. Roemer K., Friedmann T. Concept and strategies for human gene delivery. Eur. J. Biochem. 208:1992;211-225.
22. Robbins P.D., Tahara H., Ghivizzani S.C. Viral vectors for gene therapy. Trends Biotechnol. 16:1998;35-40.
23. Tsukamoto H., Boado R.J., Pardridge W.M. Site-directed deletion of a 10-nucleotide domain of the 3′-untranslated region of the GLUT1 glucose transporter mRNA eliminates cytosolic protein binding in human brain tumors and induction of reporter gene expression. J. Neurochem. 68:1997;2587-2592.
24. Walther W., Stein U. Cell type specific and inducible promoters for vectors in gene therapy as an approach for cell targeting. J. Mol. Med. 74:1996;379-392.
25. Montesano R., Pepper M.S., Mohle-Steinlein U., Risau W., Wagner E.F., Orci L. Increased proteolytic activity is responsible for the aberrant morphogenetic behavior of endothelial cells expressing the middle T oncogene. Cell. 62:1990;435-445.